See more : Harris Technology Group Limited (HT8.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Acer Medical Inc. (6857.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acer Medical Inc., a leading company in the Healthcare industry within the Healthcare sector.
- Vijaya Diagnostic Centre Limited (VIJAYA.NS) Income Statement Analysis – Financial Results
- Patel Engineering Limited (PATELENG.NS) Income Statement Analysis – Financial Results
- Olink Holding AB (publ) (OLK) Income Statement Analysis – Financial Results
- Shaily Engineering Plastics Limited (SHAILY.NS) Income Statement Analysis – Financial Results
- Winson Holdings Hong Kong Limited (6812.HK) Income Statement Analysis – Financial Results
Acer Medical Inc. (6857.TWO)
About Acer Medical Inc.
Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 27.45M | 13.06M | 9.63M | 1.01M | 0.00 |
| Cost of Revenue | 14.56M | 6.92M | 3.19M | 671.00K | 0.00 |
| Gross Profit | 12.88M | 6.14M | 6.44M | 343.00K | 0.00 |
| Gross Profit Ratio | 46.94% | 46.98% | 66.85% | 33.83% | 0.00% |
| Research & Development | 20.54M | 26.30M | 13.63M | 10.95M | 0.00 |
| General & Administrative | 24.68M | 23.36M | 10.66M | 972.00K | 0.00 |
| Selling & Marketing | 8.83M | 11.65M | 2.68M | 438.00K | 0.00 |
| SG&A | 33.51M | 35.01M | 13.34M | 1.41M | 0.00 |
| Other Expenses | 0.00 | 37.00K | -7.00K | -6.00K | 0.00 |
| Operating Expenses | 54.04M | 61.31M | 26.97M | 12.36M | 0.00 |
| Cost & Expenses | 68.61M | 68.24M | 30.16M | 13.03M | 0.00 |
| Interest Income | 2.86M | 434.00K | 93.00K | 100.00K | 113.00K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 1.00K | 1.00K |
| Depreciation & Amortization | 1.31M | 675.00K | 76.00K | 89.00K | 0.00 |
| EBITDA | -39.85M | -54.50M | -20.37M | -11.84M | -5.53M |
| EBITDA Ratio | -145.19% | -417.32% | -211.59% | -1,167.16% | 0.00% |
| Operating Income | -41.16M | -55.18M | -20.45M | -11.92M | 0.00 |
| Operating Income Ratio | -149.96% | -422.49% | -212.38% | -1,175.94% | 0.00% |
| Total Other Income/Expenses | 2.98M | 471.00K | 86.00K | 93.00K | 111.00K |
| Income Before Tax | -38.18M | -54.71M | -20.45M | -11.93M | 0.00 |
| Income Before Tax Ratio | -139.10% | -418.88% | -212.38% | -1,176.04% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -38.18M | -54.71M | -20.45M | -11.93M | 0.00 |
| Net Income Ratio | -139.10% | -418.88% | -212.38% | -1,176.04% | 0.00% |
| EPS | -2.51 | -4.43 | -2.64 | -2.29 | -1.09 |
| EPS Diluted | -2.51 | -4.43 | -2.64 | -2.29 | -1.09 |
| Weighted Avg Shares Out | 15.23M | 12.34M | 7.75M | 5.20M | 5.19M |
| Weighted Avg Shares Out (Dil) | 15.23M | 12.34M | 7.75M | 5.20M | 5.19M |
Source: https://incomestatements.info
Category: Stock Reports